These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 9544152)
21. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714 [TBL] [Abstract][Full Text] [Related]
22. Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Ponti G; Ponz de Leon M; Maffei S; Pedroni M; Losi L; Di Gregorio C; Gismondi V; Scarselli A; Benatti P; Roncari B; Seidenari S; Pellacani G; Varotti C; Prete E; Varesco L; Roncucci L Clin Genet; 2005 Nov; 68(5):442-7. PubMed ID: 16207212 [TBL] [Abstract][Full Text] [Related]
23. Microsatellite instability in Muir-Torre syndrome. Honchel R; Halling KC; Schaid DJ; Pittelkow M; Thibodeau SN Cancer Res; 1994 Mar; 54(5):1159-63. PubMed ID: 8118799 [TBL] [Abstract][Full Text] [Related]
24. Genitourinary tumors in men with the Muir-Torre syndrome. Davis DA; Cohen PR J Am Acad Dermatol; 1995 Nov; 33(5 Pt 2):909-12. PubMed ID: 7593809 [TBL] [Abstract][Full Text] [Related]
28. Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy. Landis MN; Davis CL; Bellus GA; Wolverton SE J Am Acad Dermatol; 2011 Nov; 65(5):1054-1058.e1. PubMed ID: 21550136 [TBL] [Abstract][Full Text] [Related]
29. A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene. Vernez M; Hutter P; Monnerat C; Halkic N; Gugerli O; Bouzourene H Fam Cancer; 2007; 6(1):141-5. PubMed ID: 17051350 [TBL] [Abstract][Full Text] [Related]
30. Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness. Tischkowitz M; Gologan A; Srolovitz H; Khanna M; Foulkes WD Br J Cancer; 2006 Jul; 95(2):243-4. PubMed ID: 16786041 [No Abstract] [Full Text] [Related]
31. Muir-Torre syndrome: a variant of the cancer family syndrome. Hall NR; Williams MA; Murday VA; Newton JA; Bishop DT J Med Genet; 1994 Aug; 31(8):627-31. PubMed ID: 7815421 [TBL] [Abstract][Full Text] [Related]
35. Sebaceous carcinoma, basal cell carcinoma, trichoadenoma, trichoblastoma, and syringocystadenoma papilliferum arising within a nevus sebaceus. Miller CJ; Ioffreda MD; Billingsley EM Dermatol Surg; 2004 Dec; 30(12 Pt 2):1546-9. PubMed ID: 15606837 [TBL] [Abstract][Full Text] [Related]
36. [Mutation in the MSH2 gene in Muir-Torre syndrome]. Godard V; Coulet F; Bernaudin JF; Housset M; Soubrier F Ann Dermatol Venereol; 1999; 126(8-9):600-3. PubMed ID: 10530347 [TBL] [Abstract][Full Text] [Related]
37. Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome. Svec J; Schwarzová L; Janošíková B; Stekrová J; Mandys V; Kment M; Vodička P Int J Clin Exp Pathol; 2014; 7(8):5196-202. PubMed ID: 25197397 [TBL] [Abstract][Full Text] [Related]
38. Muir-Torre syndrome: role of the dermatopathologist in diagnosis. Curry ML; Eng W; Lund K; Paek D; Cockerell CJ Am J Dermatopathol; 2004 Jun; 26(3):217-21. PubMed ID: 15166510 [TBL] [Abstract][Full Text] [Related]
39. Muir-Torre syndrome. Johnson PJ; Heckler F Ann Plast Surg; 1998 Jun; 40(6):676-7. PubMed ID: 9641292 [TBL] [Abstract][Full Text] [Related]
40. [Muir-Torre syndrome. Apropos of a case associated with a familial form of cancer]. Prunet D; Lehur PA; Guiberteau-Canfrère V; Thébaud Y; Litoux P; Le Borgne J Ann Chir; 1992; 46(10):944-6. PubMed ID: 1300910 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]